<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>etravirine</title><link>http://www.unboundmedicine.com/medline/ebm/research/etravirine</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Progress in basic and clinical research on HIV resistance: report on the XVIII International HIV Drug Resistance Workshop.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19918107/full_citation/Progress_in_basic_and_clinical_research_on_HIV_resistance:_report_on_the_XVIII_International_HIV_Drug_Resistance_Workshop_</link><description>Mascolini M, Boucher CA, Mellors JW, et al. <br/><span class="title">Progress in basic and clinical research on HIV resistance: report on the XVIII International HIV Drug Resistance Workshop. [Journal Article]</span><br/><span class="source" title="Antiviral therapy">Antivir Ther 2009; 14(7):1015-37.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19918107/abstract/Progress_in_basic_and_clinical_research_on_HIV_resistance:_report_on_the_XVIII_International_HIV_Drug_Resistance_Workshop_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19918107/full_citation/Progress_in_basic_and_clinical_research_on_HIV_resistance:_report_on_the_XVIII_International_HIV_Drug_Resistance_Workshop_">Full Citation</a></description></item><item><title>Risk of Extended Viral Resistance in Human Immunodeficiency Virus-1-Infected Mozambican Children After First-Line Treatment Failure.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19907359/full_citation/Risk_of_Extended_Viral_Resistance_in_Human_Immunodeficiency_Virus_1_Infected_Mozambican_Children_After_First_Line_Treatment_Failure_</link><description>Vaz P, Chaix ML, Jani I, et al. <br/><span class="title">Risk of Extended Viral Resistance in Human Immunodeficiency Virus-1-Infected Mozambican Children After First-Line Treatment Failure. [JOURNAL ARTICLE]</span><br/><span class="source" title="The Pediatric infectious disease journal">Pediatr Infect Dis J 2009 Nov 10.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19907359/abstract/Risk_of_Extended_Viral_Resistance_in_Human_Immunodeficiency_Virus_1_Infected_Mozambican_Children_After_First_Line_Treatment_Failure_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19907359/full_citation/Risk_of_Extended_Viral_Resistance_in_Human_Immunodeficiency_Virus_1_Infected_Mozambican_Children_After_First_Line_Treatment_Failure_">Full Citation</a></description></item><item><title>Factors associated with virological response to etravirine in non nucleoside reverse transcriptase inhibitor experienced HIV-1 infected patients.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19901096/full_citation/Factors_associated_with_virological_response_to_etravirine_in_non_nucleoside_reverse_transcriptase_inhibitor_experienced_HIV_1_infected_patients_</link><description>Marcelin AG, Flandre P, Descamps D, et al. <br/><span class="title">Factors associated with virological response to etravirine in non nucleoside reverse transcriptase inhibitor experienced HIV-1 infected patients. [JOURNAL ARTICLE]</span><br/><span class="source" title="Antimicrobial agents and chemotherapy">Antimicrob Agents Chemother 2009 Nov 9.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19901096/abstract/Factors_associated_with_virological_response_to_etravirine_in_non_nucleoside_reverse_transcriptase_inhibitor_experienced_HIV_1_infected_patients_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19901096/full_citation/Factors_associated_with_virological_response_to_etravirine_in_non_nucleoside_reverse_transcriptase_inhibitor_experienced_HIV_1_infected_patients_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19901096/Factors_associated_with_virological_response_to_etravirine_in_non_nucleoside_reverse_transcriptase_inhibitor_experienced_HIV_1_infected_patients_">Find Related Articles</a> </description></item><item><title>Etravirine: a second-generation NNRTI for treatment-experienced adults with resistant HIV-1 infection.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19881888/full_citation/Etravirine:_a_second_generation_NNRTI_for_treatment_experienced_adults_with_resistant_HIV_1_infection_</link><description>Minuto JJ, Haubrich R <br/><span class="title">Etravirine: a second-generation NNRTI for treatment-experienced adults with resistant HIV-1 infection. [JOURNAL ARTICLE]</span><br/><span class="source" title="Future HIV therapy">Futur HIV Ther 2008 Nov 1; 2(6):525-537.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19881888/abstract/Etravirine:_a_second_generation_NNRTI_for_treatment_experienced_adults_with_resistant_HIV_1_infection_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19881888/full_citation/Etravirine:_a_second_generation_NNRTI_for_treatment_experienced_adults_with_resistant_HIV_1_infection_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19881888/Etravirine:_a_second_generation_NNRTI_for_treatment_experienced_adults_with_resistant_HIV_1_infection_">Find Related Articles</a> </description></item><item><title>Validation of an Electrospray Ionization LC-MS/MS Method for Quantitative Analysis of Raltegravir, Etravirine, and 9 Other Antiretroviral Agents in Human Plasma Samples.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19865000/full_citation/Validation_of_an_Electrospray_Ionization_LC_MS/MS_Method_for_Quantitative_Analysis_of_Raltegravir_Etravirine_and_9_Other_Antiretroviral_Agents_in_Human_Plasma_Samples_</link><description>Quaranta S, Woloch C, Paccou A, et al. <br/><span class="title">Validation of an Electrospray Ionization LC-MS/MS Method for Quantitative Analysis of Raltegravir, Etravirine, and 9 Other Antiretroviral Agents in Human Plasma Samples. [JOURNAL ARTICLE]</span><br/><span class="source" title="Therapeutic drug monitoring">Ther Drug Monit 2009 Oct 27.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19865000/abstract/Validation_of_an_Electrospray_Ionization_LC_MS/MS_Method_for_Quantitative_Analysis_of_Raltegravir_Etravirine_and_9_Other_Antiretroviral_Agents_in_Human_Plasma_Samples_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19865000/full_citation/Validation_of_an_Electrospray_Ionization_LC_MS/MS_Method_for_Quantitative_Analysis_of_Raltegravir_Etravirine_and_9_Other_Antiretroviral_Agents_in_Human_Plasma_Samples_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19865000/Validation_of_an_Electrospray_Ionization_LC_MS/MS_Method_for_Quantitative_Analysis_of_Raltegravir_Etravirine_and_9_Other_Antiretroviral_Agents_in_Human_Plasma_Samples_">Find Related Articles</a> </description></item><item><title>Etravirine for HIV-1: Addressing the Limitations of the Nonnucleoside Reverse Transcriptase Inhibitor Class.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19855100/full_citation/Etravirine_for_HIV_1:_Addressing_the_Limitations_of_the_Nonnucleoside_Reverse_Transcriptase_Inhibitor_Class_</link><description>Grennan JT, Walmsley S <br/><span class="title">Etravirine for HIV-1: Addressing the Limitations of the Nonnucleoside Reverse Transcriptase Inhibitor Class. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)">J Int Assoc Physicians AIDS Care (Chic Ill) 2009 Oct 23.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19855100/abstract/Etravirine_for_HIV_1:_Addressing_the_Limitations_of_the_Nonnucleoside_Reverse_Transcriptase_Inhibitor_Class_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19855100/full_citation/Etravirine_for_HIV_1:_Addressing_the_Limitations_of_the_Nonnucleoside_Reverse_Transcriptase_Inhibitor_Class_">Full Citation</a> | <a href="http://jia.sagepub.com/cgi/pmidlookup%3fview=long%26amp;pmid=19855100">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19855100/Etravirine_for_HIV_1:_Addressing_the_Limitations_of_the_Nonnucleoside_Reverse_Transcriptase_Inhibitor_Class_">Find Related Articles</a> </description></item><item><title>Changes in Drug Resistance Patterns following the Introduction of HIV Type 1 Non-B Subtypes in Spain.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19842792/full_citation/Changes_in_Drug_Resistance_Patterns_following_the_Introduction_of_HIV_Type_1_Non_B_Subtypes_in_Spain_</link><description>De Mendoza C, Garrido C, Poveda E, et al. <br/><span class="title">Changes in Drug Resistance Patterns following the Introduction of HIV Type 1 Non-B Subtypes in Spain. [Journal Article]</span><br/><span class="source" title="AIDS research and human retroviruses">AIDS Res Hum Retroviruses 2009 Oct; 25(10):967-72.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19842792/abstract/Changes_in_Drug_Resistance_Patterns_following_the_Introduction_of_HIV_Type_1_Non_B_Subtypes_in_Spain_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19842792/full_citation/Changes_in_Drug_Resistance_Patterns_following_the_Introduction_of_HIV_Type_1_Non_B_Subtypes_in_Spain_">Full Citation</a></description></item><item><title>Pharmacological and clinical profile of Etravirine (Intelence((R))).</title><link>http://www.unboundmedicine.com/medline/ebm/record/19828928/full_citation/Pharmacological_and_clinical_profile_of_Etravirine__Intelence__R____</link><description>Iwata M, Fujii H, Yoshida S, et al. <br/><span class="title">Pharmacological and clinical profile of Etravirine (Intelence((R))). [Journal Article]</span><br/><span class="source" title="Nippon yakurigaku zasshi. Folia pharmacologica Japonica">Nippon Yakurigaku Zasshi 2009 Oct; 134(4):225-31.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19828928/full_citation/Pharmacological_and_clinical_profile_of_Etravirine__Intelence__R____">Full Citation</a> | <a href="http://joi.jlc.jst.go.jp/JST.JSTAGE/fpj/134.225%3flang=en%26amp;from=PubMed">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19828928/Pharmacological_and_clinical_profile_of_Etravirine__Intelence__R____">Find Related Articles</a> </description></item><item><title>Sustained HIV RNA suppression after switching from enfuvirtide to etravirine in the early access programme.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19828488/full_citation/Sustained_HIV_RNA_suppression_after_switching_from_enfuvirtide_to_etravirine_in_the_early_access_programme_</link><description>Loutfy M, Ribera E, Florence E, et al. <br/><span class="title">Sustained HIV RNA suppression after switching from enfuvirtide to etravirine in the early access programme. [JOURNAL ARTICLE]</span><br/><span class="source" title="The Journal of antimicrobial chemotherapy">J Antimicrob Chemother 2009 Oct 14.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19828488/full_citation/Sustained_HIV_RNA_suppression_after_switching_from_enfuvirtide_to_etravirine_in_the_early_access_programme_">Full Citation</a></description></item><item><title>Raltegravir, etravirine and r-darunavir combination in adolescents with multidrug-resistant virus.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19823069/full_citation/Raltegravir_etravirine_and_r_darunavir_combination_in_adolescents_with_multidrug_resistant_virus_</link><description>Thuret I, Chaix ML, Tamalet C, et al. <br/><span class="title">Raltegravir, etravirine and r-darunavir combination in adolescents with multidrug-resistant virus. [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="AIDS (London, England)">AIDS 2009 Nov 13; 23(17):2364-6.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19823069/abstract/Raltegravir_etravirine_and_r_darunavir_combination_in_adolescents_with_multidrug_resistant_virus_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19823069/full_citation/Raltegravir_etravirine_and_r_darunavir_combination_in_adolescents_with_multidrug_resistant_virus_">Full Citation</a> | <a href="http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm%3fissn=0269-9370%26amp;volume=23%26amp;issue=17%26amp;spage=2364">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19823069/Raltegravir_etravirine_and_r_darunavir_combination_in_adolescents_with_multidrug_resistant_virus_">Find Related Articles</a> </description></item></channel></rss>